Q2 2026 Earnings
Financial report interval: 2026.03.30 - 2026.06.30
Overview: JIUDIAN PHARMACEUTICAL(300705) the Revenue is 691.6 M (-15.24%);the EBIT is 128.25 M (-25%);the EPS is 0.364 (+10.36%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.69B15.24%
----
----
EBIT
0.13B25.00%
----
----
EPS
0.364310.36%
----
----
Revenue
ActualEstimateUnit: CNY
qf
EBIT
ActualEstimateUnit: CNY
qf
Net income
ActualEstimateUnit: CNY
qf
EPS
ActualEstimateUnit: CNY
qf